Search results for: 'consulting services in Saudi'
- Did you mean
- consisting services in saudi
- conducting services in saudi
- Related search terms
- saudi analysi of the advanced visualization solutions market
- saudi analyst of the advanced virtualization solutions market
- saudi analysi of the advanced virtualization solutions market
- saudi arabia market for facilities management 2025
- saudi of the frost chain retail market
-
19 Dec 2022  |  North America  |  Market Outlook
Top 10 for 2023: Growth Opportunities for the Life Sciences Industry
An increasing focus on biologics, genomics, and multi-omics; the adoption of digital technologies; and a shift to patient-centric models are transforming the life sciences industry. At the same time, the emergence of value-based models, R&D activities to treat complex diseases, and healthcare consumerism provide an impetus to precision medicine. Wi...
$2,450.00
Special Price $1,837.50 save 25 %
-
03 Nov 2020  |  North America  |  Frost Radar
Frost Radar™: Global Full Product Development CMO in the IVD Industry, 2020
A Benchmarking System to Spark Companies to Action—Innovation That Fuels New Deal Flow and Growth Pipelines
Full product development IVD CMO comprises companies that partner with OEMs and support them in the development of IVD devices, ranging from concept to commercialization. IVD companies are continuously looking at new ways to optimize resources due to rising cost pressures and regulatory complexities, prompting industry participants to adopt innovat...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Apr 2023  |  Asia Pacific  |  Market Outlook
Asia-Pacific Next-generation Diagnostics Outlook, 2023
The Renewed Focus on Infectious Diseases Outside COVID-9, Oncology, Cardiovascular, Diabetes, and Prenatal Care will Drive Market Growth
The Asia-Pacific next-generation diagnostics market's revenue is projected to decline by 5.0% in 2023, attributed to the reduced demand for COVID-19-related testing. Rapid expansion in non-COVID molecular diagnostics and point-of-care testing (POCT) will not be sufficient to drive the overall recovery of the region. As companies continue to focus o...
$4,950.00
Special Price $3,712.50 save 25 %
-
22 Sep 2022  |  North America  |  Market Research
AI Commercial Use Cases, Impact Analyses, and Growth Opportunities in Clinical Genomics
Integration of Clinical Genomics and AI will lead to definitive Transformational Growth in the Next Decade
Clinical genomics regained significance during the pandemic with the development of the mRNA COVID-19 vaccine, and several non-invasive at-home test kits; an unprecedented feat in recent times. Genomics will take center stage, as large genome sequencing and research will continuously create data for new therapeutics. Artificial Intelligence (AI) an...
$2,450.00
Special Price $1,837.50 save 25 %
-
22 Feb 2022  |  North America  |  Market Research
United States Liquid Biopsy Growth Opportunities
Non-invasive Liquid Biopsy Technology Shapes the Precision Diagnostics Landscape
Healthcare is rapidly becoming patient-centric, focusing on outcomes and value. This offers clinical diagnostics players opportunities to advance their instrument, assay, and informatics capabilities to address unmet clinical needs and increase the precision diagnostics portfolio. Advances in next-generation sequencing-based companion diagnosti...
$4,950.00
Special Price $3,712.50 save 25 %
-
16 Oct 2024  |  Global  |  Frost Radar
Frost Radar™: Digital Pathology, 2024
A Benchmarking System to Spark Companies to Action - Innovation That Fuels New Deal Flow and Growth Pipelines
This Frost Radar benchmarks companies offering digital pathology solutions for hospitals and laboratories and discusses opportunities in clinical, pharma, CRO, and research applications. Digital pathology solutions cover all aspects of workflow including sample collection and preparation, image acquisition and integrated image storage, and anal...
$4,950.00
Special Price $4,207.50 save 15 %
-
12 Dec 2024  |  Global  |  Market Outlook
Top 6 Growth Opportunities for Clinical Diagnostics, Global, 2025
Approval of New Tests and Laboratory Automation Solutions are Driving Transformational Growth
Accounting for 2%-3% of total healthcare expenditure and influencing 70% of clinical decision-making, diagnostics is the silent champion supporting all stages of precision health, including risk stratification, screening, early diagnosis, prognosis, monitoring, and relapse. The discovery and translation of blood-based neurology biomarkers, sustai...
$2,450.00
Special Price $2,082.50 save 15 %
-
11 Dec 2020  |  North America  |  Market Research
Demand for High-Volume Testing Driving the Growth of the US Clinical Chemistry and Immunoassay In Vitro Diagnostics Market, 2020
Serology Assays for COVID-19 Diagnosis Present an Immediate Growth Opportunity
The Transformational Health team at Frost & Sullivan provides critical insights into the US clinical chemistry and immunoassay industry, highlighting the recent activities, key growth opportunities, and trends that are shaping the industry. The already dynamic in vitro diagnostics landscape in the United States was affected even more by the recen...
$2,450.00
Special Price $1,837.50 save 25 %
-
23 Aug 2019  |  South Asia, Middle East & North Africa  |  Market Outlook
Middle East and North Africa (MENA) Life Sciences Industry Outlook, Forecast to 2020
Increased Local Manufacturing and Government Spending on Lifestyle Diseases to be Key Driving Factors in 2020
In this research deliverable, Frost & Sullivan’s analyst team provides bold perspectives and predictions for the Middle East and North Africa (MENA) region’s life sciences industry in 2020. The markets covered include pharmaceuticals, biotechnology, and in-vitro diagnostics. The analysis captures the impact of trends that are expected to transpire ...
$4,950.00
Special Price $3,712.50 save 25 %
-
20 Mar 2019  |  North America  |  Market Research
2019 Predictions of the Global Life Sciences Industry
As Novel Technologies Find Traction, Industry Focus Will Shift Towards Successful Monetization to Deliver Value-based Care
he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...
$1,500.00
Special Price $1,125.00 save 25 %